Name | PI4KIIIbeta-IN-11 |
---|
Description | PI4KIIIbeta-IN-11 is an inhibitor of PI4KIIIβ, with a mean pIC50 value of at least 9.1. PI4KIIIβ plays a key role in diseases research of RNA viruses and Plasmodium falciparum[1][2]. |
---|---|
Related Catalog | |
Target |
PI4KIIIβ:9.1 (pIC50) |
In Vitro | PI4KIIIβ may be a relevant target protein for inhibition of Hedgehog signaling, and regulates trafficking from the Golgi system to the plasma membrane[1]. PI4KIIIbeta-IN-11 (compound 22) (0.5 μM; 0-45 min) shows metabolic stability in human microsomes, with the intrinsic clearance of 33.7 mL/min/g[2]. |
In Vivo | PI4KIIIbeta-IN-11 (compound 22) (1 mg/kg; i.v.; last over 1 h) displays a low spleen concentration in rats[2]. Animal Model: Male Wistar Han Rats[2] Dosage: 1 mg/kg Administration: Intravenous injection, formulated in 2% DMSO in Kleptose (aq, 10% w/v); over 1 hour; euthanised at 12 h Result: Showed a low concentration in spleen of 5.54 ng/g. |
References |
Molecular Formula | C33H39N7O3 |
---|---|
Molecular Weight | 581.71 |